Flexible and managed workspace provider Enzyme Offices has announced plans to double its revenue in the current financial year, targeting ₹150 crore, up from ₹75 crore in FY25. The company also aims to achieve an annual recurring revenue (ARR) of ₹200 crore by 2026-27, driven by growing demand from both global capability centres (GCCs) and leading Indian startups.
Ashish Agarwal, Founder and CEO of Enzyme Offices, highlighted that the company will support this growth with a planned investment of ₹50 crore. The investment will focus on expanding operations, enhancing infrastructure, and strengthening technology capabilities across its managed workspace portfolio. ARR, a key metric for subscription-based and long-term leasing businesses, represents the recurring revenue of contracts normalized over a year.
Enzyme Offices has witnessed a significant increase in adoption among businesses starting with small setups of 20-30 seats, which have scaled to over 600 seats within its spaces. Among the company’s marquee clients are Vyapar, Teachmint, Dukaan, Avin Systems, and Stellar Innovations. In one recent milestone, Enzyme Offices delivered a nearly 1 lakh sq. ft. workspace to Vyapar, generating a monthly rental income of ₹1 crore.
The company’s focus remains on offering flexible and managed workspaces that cater to enterprises, startups, and small and medium-sized enterprises (SMEs) across India. This approach addresses evolving business needs, including scalable office solutions, operational efficiency, and a supportive infrastructure for corporate growth.
Enzyme Offices’ strategy reflects broader trends in India’s office leasing market, where demand for flexible workspaces has been rising among technology-driven enterprises and global capability centres. The combination of flexible office layouts, managed facilities, and strategic locations has positioned companies like Enzyme Offices to attract high-value clients seeking scalable office solutions.
Industry experts note that the sector is experiencing steady growth, with startups and expanding enterprises looking for high-quality office infrastructure without the long-term capital commitment required for traditional leased or owned office spaces. Enzyme Offices’ planned investment is expected to further enhance its capacity to meet this demand and strengthen its position in India’s competitive flexible office market.
With its expansion and revenue target plans, Enzyme Offices aims to consolidate its market presence and establish a robust platform for long-term growth, providing scalable workspace solutions while leveraging technology and operational efficiencies to serve a diverse client base.
.png)